Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
ANTIBODIES AND MEDIATORS OF IMMUNITY

Opsonophagocytosis of Fluorescent Polystyrene Beads Coupled to Neisseria meningitidis Serogroup A, C, Y, or W135 Polysaccharide Correlates with Serum Bactericidal Activity

Joseph Martinez, Tamara Pilishvili, Suzanne Barnard, Joseph Caba, Willie Spear, Sandra Romero-Steiner, George M. Carlone
Joseph Martinez
1Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jmartinez@cdc.gov
Tamara Pilishvili
1Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Barnard
2University of Glasgow, Glasgow, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Caba
1Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willie Spear
1Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Romero-Steiner
1Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George M. Carlone
1Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CDLI.9.2.485-488.2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We developed a polysaccharide-specific flow cytometric opsonophagocytic assay (OPA) for the simultaneous measurement of functional antibody to Neisseria meningitidis serogroups A, C, Y, and W135. OPA titers significantly correlated with serum bactericidal assay titers for all serogroups tested (mean r = 0.96; P < 0.001). OPA could be used in meningococcal vaccine evaluation.

Meningococcal disease continues to be a significant cause of morbidity and mortality in the United States and worldwide (3). The primary mechanism of protection from disease is through antibody- and complement-dependent bactericidal activity (9). Antibodies to capsular polysaccharides of groups A and C of Neisseria meningitidis have been shown to confer protection from meningococcal disease (1, 7).

N. meningitidis is efficiently phagocytosed by polymorphonuclear (PMN) cells (5, 8, 10), and antibodies specific for group A and C polysaccharides are bactericidal in the presence of peripheral blood polymorphonuclear leukocytes and complement (19). Monocytes can also phagocytose Neisseria species (12, 13, 16, 23). The relative importance of opsonophagocytic killing as a defense mechanism against N. meningitidis has been previously demonstrated (2, 4, 18, 20, 22). Opsonophagocytic assays (OPA) offer several advantages over the standard serum bactericidal assay (SBA). OPA for other pathogens such as Streptococcus pneumoniae have been developed which are semi-automated, use noninfectious targets, provide useful laboratory correlates of protection, and can be multiplexed (14).

This report describes a patent-pending multiplexed flow cytometric OPA for measurement of antibody- and complement-dependent cell-mediated antimeningococcal activity against serogroups A, C, Y, and W135. Postvaccination sera were collected 1 month after immunization with a quadrivalent meningococcal vaccine (Menomune; Connaught Laboratories, Philadelphia, Pa). Sera from nonimmunized adults (n = 15) and postvaccination adults (n = 12) were obtained through the Emory University Donor Services, Atlanta, Ga., and used as quality controls (15). Sera were stored at −70°C and heat inactivated at 56°C for 30 min just before being tested, to inactivate endogenous complement activity. We compare this flow OPA technique to a previously standardized SBA (15).

(Part of this study was presented at the 11th International Pathogenic Neisseria Conference, Nice, France, 1998.)

Homologous capsular polysaccharide from meningococcal serogroups A, C, Y, and W135 (Connaught Laboratories) at a concentration of 1 mg/ml was oxidized by the addition of 218 μl of a 0.046 M sodium periodate solution for 30 min, protected from light, at room temperature. The reaction was stopped by the addition of 0.1 ml of glycerol per ml of reaction solution. The polysaccharide solutions were then dialyzed overnight against 0.1 M sodium bicarbonate buffer (pH 8.0).

Aliquots (100 μl) from the commercial preparation of 1-μm-diameter carboxylate-modified FluroSpheres (Molecular Probes, Eugene, Oreg.) were coupled with each oxidized meningococcal polysaccharide. Bead populations with different fluorescent spectra were used for each serogroup polysaccharide (serogroup A, 565 nm excitation/580 nm emission; serogroup C, 625 nm/645 nm; serogroup Y, 488 nm/525 nm; serogroup W135, 540 nm/560 nm). The beads were washed twice in 0.1 M sodium phosphate-0.15 M sodium chloride buffer for 15 min at 16,110 × g, after which the supernatant was removed. Then 1 ml of adipic acid buffer (containing 0.22 M adipic acid dihydrazide dissolved in 0.1 M sodium phosphate-0.15 M sodium chloride buffer) was added to the bead pellet. Water-soluble carboiimide ECD (0.08 M) was added to the bead suspension, and the mixture was left at room temperature for 4 h. The activated beads were then washed three times for 5 min at 16,110 × g and resuspended in 0.1 M bicarbonate buffer (pH 8.0). The bead suspension was mixed with 1 ml of periodate-oxidized polysaccharide solution, and 10 μl of a 5 M sodium cyanoborohydride solution was added. This reaction mixture was then left in the dark for 2 h at room temperature to covalently bind the polysaccharide to the beads. The beads were washed four times in opsonophagocytosis buffer (Hanks balanced salt solution [Life Technologies, Rockville, Md.] with Ca2+ and Mg2+, 0.2% bovine serum albumin, 1× penicillin-streptomycin solution [Life Technologies]), resuspended in 1 ml of opsonophagocytosis buffer, and stored at 4°C, protected from light. All chemicals were of reagent grade and were purchased from Sigma Chemical Co., St. Louis, Mo.

HL-60 human promyelocytic leukemia cells (CCL240; American Type Culture Collection, Rockville, Md.) were differentiated into monocytes by being cultured in the same medium supplemented with 1 mM n-butyric acid dissolved in Hanks buffered salt solution containing Ca2+ and Mg2+ (Life Technologies). The differentiation was allowed to continue for 4 days (21).

Eight twofold serum dilutions were made in opsonophagocytosis buffer from 10 μl of test serum. A 20-μl aliquot of bead suspension containing 105 beads (the bead suspension was counted using a hemacytometer) was added to each well, and the plate was incubated for 90 min at 37°C with horizontal shaking (200 rpm). Following this, 10 μl of sterile serum from 3- to 4-week old baby rabbits (Pel-Freez, Brown Deer, Wis.) was added to each well as a source of complement, with the exception of the HL-60 cell control wells, which received 10 μl of opsonophagocytosis buffer. After incubation of the mixture at 37°C in room air for 15 min with shaking, 40 μl of washed monocytes (105 cells) was added to each well, resulting in an effector-to-target ratio of 1:1, and the plates were incubated with shaking at 37°C in air for an additional 15 min. The final well volume was 80 μl. To provide sufficient volume for flow cytometer analysis, an additional 100 μl of opsonophagocytosis buffer was added to each well. The well contents were resuspended and transferred into titer tubes (Bio-Rad Laboratories, Richmond, Calif.). The titer tubes were placed inside 12- by 75-mm polystyrene disposable tubes (Fisher, Atlanta, Ga.) for flow cytometric analysis. The cytometer was optimized to collect data from four different fluorescence detectors (FL1, 525 nm; FL2, 560 nm; FL3, 580 nm; FL4, 645 nm) by adjusting instrument compensation to minimize spectral overlap.

Samples were assayed with a FACSCalibur immunocytometry system (Becton Dickinson, San Jose, Calif.). Data were collected and analyzed with CELLQuest software (Becton Dickinson, version 1.2 for Apple system 7.1). Samples with a maximum phagocytic uptake of <20% were considered negative and reported as a titer of 4 for analysis purposes.

The meningococcal SBA for all serogroups was carried out using a previously published method (15). Pearson's product moment correlation coefficient, for normally distributed data, and the Mann-Whitney rank sum test, for non-normally distributed data, were used for statistical analysis of the data, with significance levels set at <0.05. Sigma Stat software program, version 2.0 (Jandel Scientific, San Rafael, Calif.) was used.

This standardized, multiplexed flow cytometric OPA can measure the opsonic activity of antibodies produced in response to the quadrivalent meningococcal polysaccharide vaccine. Homologous absorption studies using A, C, Y, or W135 polysaccharide (200 μg/ml) resulted in a mean decrease in titer of ≥98% when testing for specific antibodies against the absorbed serogroup. The geometric mean titers (GMTs) for postvaccination sera using the SBA were as follows: A = 3,405, C = 2,409, Y = 3,405, and W135 = 2,864. The GMTs obtained on the postvaccination sera with the four-serogroup OPA were as follows: A = 3822, C = 3215, Y = 4288, and W135 = 2146. Although the SBA and OPA are different functional assays, no significant differences in GMTs were obtained by these two methods when tested by the Mann-Whitney rank sum method (all P > 0.64). Figure 1 shows the comparison between the SBA and the multicolor, multiserogroup flow OPA. Correlations between the SBA, single-serogroup OPA, and multiserogroup OPA were good (Table 1). The data demonstrated that there was good correlation (all P ≤ 0.01) in the titers obtained by individually testing human sera for an opsonic antibody to a single serogroup or testing the same sera simultaneously for serogroups A, C, Y, and W135 by the multicolor flow cytometric OPA. Correlations between the SBA and the multiplexed OPA on all sera (from nonimmunized and immunized persons) were very good (r > 0.94; P < 0.001). Our results clearly demonstrate that both the SBA and OPA may be used as indicators of functional antibody production in individuals vaccinated with meningococcal polysaccharide vaccines and that simultaneous measurement of OPA activity does not affect the observed OPA titers.

The current method of choice for measuring functional antibodies directed against N. meningitidis is the SBA. However, this assay is highly sensitive to complement sources, and marked differences in SBA titers have been observed depending on the complement used (15; G. Santos, B. Wacknov, R. Borrow, W. Leong, L. Danzig, A. Langenberg, D. Granoff, R. Deck, and J. Donnelly, Program Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 53, p. 238, 2000). A fluorescence-based SBA has also been developed and substantially reduces the assay time (17) compared with the standard SBA. Neither the standard SBA nor the newer fluorescence-based SBA is capable of simultaneously measuring functional antimeningococcal polysaccharide antibodies against different serogroups.

In vitro, an intact complement pathway is required for optimal serum bactericidal activity whereas only the early complement components (deposition of C3) are required for opsonophagocytic activity. Both mechanisms appear to operate in the host to clear meningococci (6, 7, 9, 23). To date, the opsonophagocytic mechanism of bacterial clearance has not been used as a measure of functional antibody production in response to meningococcal polysaccharide vaccines.

The flow cytometric OPA has several advantages over the standard SBA. This flow cytometric OPA requires less time, uses noninfectious targets, requires less test serum, uses fluorescent beads which are not sensitive to the presence of antibiotics or to the source of complement, and has been adapted to measure functional antibodies against multiple serogroups simultaneously. These advantages make the flow cytometric OPA an attractive alternative to the SBA for assessing the protective potential of polysaccharide-based N. meningitidis A/C/Y/W135 vaccines. We developed but did not validate a serogroup-specific flow cytometric opsonophagocytic method to measure opsonizing antibodies produced in response to a quadravalent meningococcal polysaccharide vaccine. Our goal was to establish the concept of a multiserogroup N. meningitidis OPA capable of simultaneous measurement of opsonic antibodies to serogroups A, C, Y, and W135. Our method uses four different types of fluorescent microspheres each covalently bound to one of either serogroup A, C, Y, or W135 meningococcal polysaccharide and HL-60 cell line-derived monocytes to assess complement-dependent functional antimeningococcal polysaccharide antibodies in healthy adults. This assay will eventually be used to evaluate opsonic activity in sera from individuals vaccinated with one or more doses of conjugate vaccine. While the use of fluorescent beads as targets in a flow cytometric assay is not unique (11, 24), to our knowledge this is the first assay to use multiple fluorescent bead populations to determine opsonophagocytic activity simultaneously against multiple specific bacterial antigens (patent pending #60/192,712). This type of methodology will require future validation and determination of assay sensitivity with low- and high-titer serum from vaccinated populations.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Comparison of SBA and multi serogroup flow cytometric opsonophagocytic titers obtained from 15 nonimmunized adults and 12 adults immunized with one dose of an N. meningitidis polysaccharide vaccine.

View this table:
  • View inline
  • View popup
TABLE 1.

Comparison between SBA and flow cytometric OPA for N. meningitidis serogroups A, C, Y, and W135 in postvaccination adult sera.

FOOTNOTES

    • Received 13 August 2001.
    • Returned for modification 25 September 2001.
    • Accepted 5 December 2001.
  • Copyright © 2002 American Society for Microbiology

REFERENCES

  1. 1.↵
    Artenstein, M. S., R. Gold, J. G. Zimmerly, F. A. Wyle, H. Scheneider, and C. Haskins. 1970. Prevention of meningococcal disease by group C polysaccharide vaccine. N. Engl. J. Med.282:417-420.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    Bredius, R. G. M., B. H. F. Derkx, A. P. Fijen, T. P. M. de Wit, M. de Haas, R. S. Weening, J. G. J. van de Winkel, and T. A. Out. 1994. Fcγ receptor Iia (CD32) polymorphism in fulminent meningococcal shock in children. J. Infect. Dis.170:849-853.
    OpenUrl
  3. 3.↵
    Centers for Disease Control and Prevention. 2000. Recommendations of the Advisory Committee on Immunization Practices concerning the control and prevention of meningococcal disease. Morb. Mortal. Wkly. Rep.49(RR07):1-10.
    OpenUrlPubMed
  4. 4.↵
    Estabrook, M. M., N. C. Christopher, J. M. Griffiss, C. J. Baker, and R. E. Mandrell. 1992. Sialylation and human neutrophil killing of group C Neisseria meningitidis. J. Infect. Dis.166:1079-1088.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Fredlund, A., P. Olcen, and D. Danielsson. 1988. A reference procedure to study chemiluminesence induced in polymorphonuclear leukocytes by Neisseria meningitidis. Acta Pathol. Microbiol. Immunol. Scand. Sect. C96:941-949.
    OpenUrl
  6. 6.↵
    Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med.129:1237-1248.
    OpenUrl
  7. 7.↵
    Goldschneider, I., E. C. Gotschlich, and M. S. Artensen. 1969. Human immunity to the meningococcus. I. The role of human antibodies. J. Exp. Med.129:1307-1326.
    OpenUrlAbstract
  8. 8.↵
    Gomez-Lus, M. L., L. Aguilar, J. Vazquez, M. J. Gimenez, G. Ruiz, S. Berron, F. Fuentes, and J. Prieto. 2000. Ex vivo bactericidal activity against group C Neisseria meningitidis in seronegative subjects. Infection28:305-308.
    OpenUrlCrossRefPubMed
  9. 9.↵
    Gotschich, E. C., I. Goldschneider, and M. S. Artenstein. 1969. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J. Exp. Med.129:1367-1384.
    OpenUrlAbstract
  10. 10.↵
    Halstensen, A., H. Sjursen, S. E. Vollset, L. O. Froholm, A. Naess, R. Matre, and C. O. Solberg. 1989. Serum opsonins to serogroup B meningococci in meningococcal disease. J. Infect. Dis.21:267-276.
    OpenUrl
  11. 11.↵
    Lehmann, A. K., A. Halstensen, and C. F. Bassoe. 1998. Flow cytometric quantitation of human opsonin-dependent phagocytosis and oxidative burst responses to meningococcal antigens. Cytometry33:406-413.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Lowell, G. H., L. F. Smith, M. S. Artenstein, G. S. Nash, and R. P. MacDermott, Jr. 1979. Antibody dependent cell-mediated antibacterial activity of human mononuclear cells. J. Exp. Med.150:127-137.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Lowell, G. H., L. F. Smith, J. M. Griffis, B. L. Brandt, and R. P. MacDermott, Jr. 1980. Antibody dependent mononuclear cell-mediated antimeningococcal activity. J. Clin. Investig.66:260-267.
    OpenUrlPubMed
  14. 14.↵
    Martinez, J. E., S. Romero-Steiner, T. Pilishvili, S. Barnard, J. Schinsky, D. Goldblatt, and G. M. Carlone. 1999. A flow cytometric opsonophagocytic assay for the measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin. Diagn. Lab. Immun.6:581-586.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Maslanka S. E., L. L. Gheesling, D. E. Libutti, K. B. Donaldson, H. S. Harakeh, J. K. Dykes, F. F. Arhin, S. J. Devi, C. E. Frasch, J. C. Huang, P. Kriz-Kuzemenska, R. D. Lemmon, M. Lorange, C. C. Peeters, S. Quataert, J. Y. Tai, and G. M. Carlone. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin. Diagn. Lab. Immunol.4:156-167.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    Mezzatesta, J. R., and R. F. Rest. 1983. Phagocytic killing of Neisseria gonorrhoeae by human monocytes. Infect. Immun.42:99-103.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Mountzouros, K. T., and A. P. Howell. 2000. Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis. J. Clin. Microbiol.38:2878-2884.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Raff, H. V., D. Devereux, W. Shuford, D. Abbot-Brown, and G. Maloney. 1988. Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections. J. Infect. Dis.157:118-126.
    OpenUrlCrossRefPubMed
  19. 19.↵
    Roberts, R. B. 1970. The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man. J. Exp. Med.131:499-513.
    OpenUrlAbstract
  20. 20.↵
    Ross, S. C., P. J. Rosenthal, H. M. Berberich, and P. Densen. 1987. Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals. J. Infect. Dis.155:1266-1275.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    Rovera, G. D. Santoli, and C. Damsky. 1979. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. USA76:2779-2783.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    Schlesinger, M., R. Greenberg, J. Levy, H. Kaythy, and R. Levy. 1994. Killing of meningococci by neutrophils: effect of vaccination on patients with complement deficiency. J. Infect. Dis.170:449-453.
    OpenUrlCrossRefPubMed
  23. 23.↵
    Smith, L. F., and G. H. Lowell. 1980. Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. II. Immune specificity of antimeningococcal activity. J. Infect. Dis.141:748-751.
    OpenUrlCrossRefPubMed
  24. 24.↵
    Uff, C. R., A. G. Pockley, and R. K. S. Phillips. 1993. A rapid microplate-based fluorometric assay for phagocytosis. Immunol. Investig.22:407-413.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Opsonophagocytosis of Fluorescent Polystyrene Beads Coupled to Neisseria meningitidis Serogroup A, C, Y, or W135 Polysaccharide Correlates with Serum Bactericidal Activity
Joseph Martinez, Tamara Pilishvili, Suzanne Barnard, Joseph Caba, Willie Spear, Sandra Romero-Steiner, George M. Carlone
Clinical and Diagnostic Laboratory Immunology Mar 2002, 9 (2) 485-488; DOI: 10.1128/CDLI.9.2.485-488.2002

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Opsonophagocytosis of Fluorescent Polystyrene Beads Coupled to Neisseria meningitidis Serogroup A, C, Y, or W135 Polysaccharide Correlates with Serum Bactericidal Activity
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Opsonophagocytosis of Fluorescent Polystyrene Beads Coupled to Neisseria meningitidis Serogroup A, C, Y, or W135 Polysaccharide Correlates with Serum Bactericidal Activity
Joseph Martinez, Tamara Pilishvili, Suzanne Barnard, Joseph Caba, Willie Spear, Sandra Romero-Steiner, George M. Carlone
Clinical and Diagnostic Laboratory Immunology Mar 2002, 9 (2) 485-488; DOI: 10.1128/CDLI.9.2.485-488.2002
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X